Federal award (PURCHASE ORDER, fiscal year 2021)
Recipient: UNIVERSITY OF KANSAS CENTER FOR RESEARCH INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-09-29 to 2021-12-31
Current total value of award: $18800
Description: IPP-B PURPOSE: GIVEN THE PREVIOUSLY SCREENED PHYSICOCHEMICAL PROPERTIES OF THE ML290 DRUG CANDIDATE, INVESTIGATE THE FEASIBILITY OF GENERATING A PROGRESSABLE FORMULATION STRATEGY FOR CLINICAL EVALUATION; TIER 1 FORMULATION STRATEGY IDENTIFICATION FOR